Abstract

The prototypical model for NOD-like receptor (NLR) inflammasome assembly includes nucleotide-dependent activation of the NLR downstream of pathogen- or danger-associated molecular pattern (PAMP or DAMP) recognition, followed by nucleation of hetero-oligomeric platforms that lie upstream of inflammatory responses associated with innate immunity. As members of the STAND ATPases, the NLRs are generally thought to share a similar model of ATP-dependent activation and effect. However, recent observations have challenged this paradigm to reveal novel and complex biochemical processes to discern NLRs from other STAND proteins. In this review, we highlight past findings that identify the regulatory importance of conserved ATP-binding and hydrolysis motifs within the nucleotide-binding NACHT domain of NLRs and explore recent breakthroughs that generate connections between NLR protein structure and function. Indeed, newly deposited NLR structures for NLRC4 and NLRP3 have provided unique perspectives on the ATP-dependency of inflammasome activation. Novel molecular dynamic simulations of NLRP3 examined the active site of ADP- and ATP-bound models. The findings support distinctions in nucleotide-binding domain topology with occupancy of ATP or ADP that are in turn disseminated on to the global protein structure. Ultimately, studies continue to reveal how the ATP-binding and hydrolysis properties of NACHT domains in different NLRs integrate with signaling modules and binding partners to control innate immune responses at the molecular level.

Highlights

  • The prototypical model for NOD-like receptor (NLR) inflammasome assembly includes nucleotide-dependent activation of the NLR downstream of pathogen- or danger-associated molecular pattern (PAMP or DAMP) recognition, followed by nucleation of hetero-oligomeric platforms that lie upstream of inflammatory responses associated with innate immunity

  • Given disparities in the precise NACHT sequence identified within several NLRPs, it is justifiable to predict that distinctions in the kinetics and effect of ATP hydrolysis exist for the various family members

  • An additional study revealed that disrupting the ATP-binding efficacy of NLRP3 with mutation of the Walker A motif could inactivate a constitutively-active variant of the NLRP3 inflammasome that possessed an Arg258Trp cryopyrin-associated periodic syndrome (CAPS)-associated mutation within the NACHT

Read more

Summary

Inflammasomes and Innate Immunity

Cells have developed an innate ability to respond to infectious pathogens as well as endogenous molecules that arise from cellular injury. Their comparable large sizes and composite domain structure enable the nucleation of high molecular weight signaling complexes, thereby recruiting effectors and activating downstream signal transduction events Their modular domain assemblies frequently combine variable N-terminal effector domains and C-terminal superstructure-forming sensor repeats with a central, conserved ATPase domain, supporting the importance of this domain in a family of signaling foci. The prototypical model of inflammasome assembly includes nucleotide-dependent activation of the NLR downstream of PAMP or DAMP recognition This event is followed by nucleation of hetero-oligomeric inflammasome platforms that lie upstream of the inflammatory responses associated with innate immunity [19,20]. The NLRC proteins contain a CARD-NACHT-LRR domain organization, whereas a PYD-NACHT-LRR construct is most conserved for the NLRPs (Figure 1A) Exceptions to this structural domain organization include NLRP1 which has an additional C-terminal Function to. ASC, which recruits pro-caspase-1 via CARD-CARD interactions

Selective Tissue Expression Profiles
Epigenetic Programming and Innate Immune Memory
NLR Links between the Innate and Adaptive Immune Systems
NLRs are STAND ATPases
NLR Phylogeny
The Importance of ATP in NLR Activation
ATP-Dependency for the Assembly and Activation of Selected NLR Inflammasomes
NLRP12
A Molecular Description of the NACHT Domain
Structural Basis for Inflammasome Assembly Mechanisms
Pharmacological Inhibitors of NLRP3 ATPase Activity
Small moleculewhich inhibitors the ATPase
MCC950
Parthenolide and Bay11-7082
BOT-4-One
Findings
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call